COMMUNIQUÉS West-GlobeNewswire

IBA – Rachat d’actions propres
24/03/2025
Louvain-la-Neuve, Belgique, 24 mars 2025 - Ion Beam Applications SA (IBA) a annoncé aujourd’hui le lancement d’un programme de rachat d’actions propres à compter du 25 mars 2025, en application de l’article 7:215 du [...]
Better Choice Announces SRx Health’s Participation at the 2025 Bloom Burton & Co. Healthcare Investor Conference on May 5th and 6th
24/03/2025
TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that SRx Health’s management team will be [...]
Prime Biome Shortages Explained: Restock Updates & Where to Buy
24/03/2025
ST. PETERSBURG, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Shoppers searching for PrimeBiome gummies may have noticed limited availability in recent weeks due to overwhelming consumer demand. The brand's increasing [...]
Transactions under Novonesis’ share buyback program
24/03/2025
Please read the announcement in PDF Attachment 2025_13_Share_buyback_program
Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting
24/03/2025
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics presented results showing a refined approach to detect drug-induced testicular toxicity using Singlera’s cell-free DNA methylation technology with Astellas [...]
PatchMD Launches Innovative Mito Cocktail Patch to Support Mitochondrial Health in Individuals with Autism Spectrum Disorder (ASD)
24/03/2025
Las Vegas, NV, March 24, 2025 (GLOBE NEWSWIRE) -- PatchMD, a leader in innovative nutrient delivery systems, proudly announces the launch of its new Mito Cocktail Patch , designed to support mitochondrial function for [...]
Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care
24/03/2025
March 24, 2025 Interoperable AI-powered digital pathology workflows support confident cancer diagnosis Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today [...]
Recovery First Treatment Center’s New Executive Director Pledges to Expand Access, Strengthen Addiction Treatment Services
24/03/2025
HOLLYWOOD, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- As the overdose crisis continues to affect communities across South Florida, Recovery First Treatment Center has appointed Mercy Estevez, MSW, LCSW, as its new [...]
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
24/03/2025
BUBENDORF, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to [...]
Après une inspection réussie de l’ANSM, CARBOGEN AMCIS obtient la certification BPF pour son site de fabrication de produits pharmaceutiques aseptiques
24/03/2025
BUBENDORF, Suisse, 24 mars 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS, société suisse leader dans le développement de procédés pharmaceutiques et la fabrication d’ingrédients pharmaceutiques actifs (API), a le plaisir d’ [...]
Anaptys Announces Stock Repurchase Plan
24/03/2025
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its Board of Directors [...]
Advanced Medical Balloons announces its new hygh-tec Odor Solution™ product, broadening its catheter portfolio
24/03/2025
hygh-tec Odor Solution™ will be launched in Q2 2025 FDA clearance and MDR certification already secured First generation hygh-tec™ catheter rapidly achieved more than a third of the market share in Germany, and [...]
Survey Projects High Turnover Rates Among Healthcare Executives in 2025
24/03/2025
46% Plan to Leave Their Organizations in the Next 12 Months DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Close to half of hospital, medical group and other healthcare facility leaders intend to leave their organizations [...]
PharmAla Contracts with Partner to Act as US Distributor
24/03/2025
TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners
24/03/2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath Pathology Services, Inc. , Peninsula Pathology Medical Group (PPMG) , Pathology Group of [...]
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
24/03/2025
Company prioritizes ophthalmology pipeline programs with potential to provide new or improved treatment options in multiple severe and disabling eye diseases Announces an oversubscribed financing of $175 million in [...]
Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol
24/03/2025
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a [...]
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
24/03/2025
CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development [...]
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
24/03/2025
Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a [...]

Pages